Gold prices edge higher on raised Fed rate cut hopes
Investing.com - PAVmed reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
PAVmed announced earnings per share of $-0.150 on revenue of $76K. Analysts polled by Investing.com EPS of $-0.270 on revenue of $233.33K.
PAVmed 's are down 60% and is trading at $0.990 , still down 81.06% from its 52 week high of $5.08 set on Monday, November 15, 2021.
PAVmed shares gained 2.91% to trade at $0.990 in after-hours trade the report.
PAVmed follows other major Healthcare sector earnings this month
PAVmed's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar